Conversely, it has been found that the genotype GSTP1 A/A is predicted to show a suboptimal response to chemotherapy with fluorouracil/cisplatin, and a lower survival rate in patients with advanced gastric cancer (Ruzzo et al., 2006). The gene discussed is GSTP1; the disease is gastric cancer.